WASHINGTON, D.C. — September 25, 2014 — The Sabin Vaccine Institute (Sabin) today announced that effective October 17, 2014, Dr. Jon Andrus will join Sabin as Executive Vice President and Director of Vaccine Advocacy and Education. In this role, he will leverage more than three decades of experience as a global health leader with a well-documented record for fostering collaboration among national governments and partners to expand access to vaccines for the world’s poorest people.
Durban, South Africa — 22 September 2014 — The International Association of Immunization Managers (IAIM) Secretariat, based at the Sabin Vaccine Institute (Sabin), today announced it will hold its first-ever regional meeting for members from the Middle East and Africa on 25-26 September 2014 in Durban, South Africa.
WASHINGTON, D.C. — September 16, 2014 — The Sabin Vaccine Institute (Sabin) today announced that its product development partnership (Sabin PDP) received $2 million from the Global Health Innovative Technology Fund (GHIT Fund) to develop a new therapeutic vaccine formulation for Chagas disease. Baylor College of Medicine, Eisai Co., Ltd. (Eisai) and Aeras are partnering on this project with the Sabin PDP, based at the Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development in Houston, Texas.